ArticleFrontiers in cardiovascular medicine2025
FOS as a biomarker for myocardial infarction treatment with Deng's Yangxin Decoction: a systems biology-based analysis.
Junfeng Fang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.